Table 1.
Input parameters | Direct costs, $ | Probability | Time, d | Utility | Range | Sources |
---|---|---|---|---|---|---|
Screening costs | ||||||
Mammography | 187 | N/A | 0.25 | — | — | Plevritis et al., 2006 (16), and Mittmann et al., 2015 (17) |
Magnetic resonance imaging | 631 | N/A | 0.5 | — | — | Mittmann et al., 2015 (17), and Pataky et al., 2013 (30) |
Clinical diagnosis | 229 | N/A | 0.5 | — | — | de Bock et al., 2013 (31) |
Invasive work-up | 0.15 | — | — | Mittmann et al., 2014 (29) | ||
Needle biopsy | 761 | 0.82 | 1 | — | — | Plevritis et al., 2006 (16), and Mittmann et al., 2014 (29) |
Excisional biopsy | 1687 | 0.18 | 2 | — | — | Plevritis et al., 2006 (16), and Mittmann et al., 2014 (29) |
Non invasive work-up | 455 | 1.0 | 0.25 | — | — | Plevritis et al., 2006 (16), and Mittmann et al., 2014 (29) |
Assumed baseline utilities | ||||||
Breast cancer free | NA | 1.0 | N/A | 0.84 | (0.76, 1.00) | Cappelli et al., 2001 (20), Antoniou et al., 2003 (21), and Ara and Wailoo, 2011 (22) |
Undiagnosed breast cancer | NA | 1.0 | N/A | 0.84 | (0.76, 1.00) | Cappelli et al., 2001 (20), Antoniou et al., 2003 (21), and Ara and Wailoo, 2011 (22) |
*N/A = not applicable.